Monoclonal antibody of 100 µl targeting Pseudouridine for ICC, IHC, ELISA.
| Product Specifications | |
| Application | ICC, IHC, ELISA |
| Clonality | Monoclonal IgG2a ĸ |
| Host | Mouse |
| Immunogen | KLH-conjugated pseudouridine |
| Formulation | 1 mg/mL in PBS/50% glycerol, pH 7.2 |
| Citations for Anti-Pseudouridine mAb (Clone: APU-6) – 3 Found |
| Mishima, Eikan; Jinno, Daisuke; Akiyama, Yasutoshi; Itoh, Kunihiko; Nankumo, Shinnosuke; Shima, Hisato; Kikuchi, Koichi; Takeuchi, Yoichi; Elkordy, Alaa; Suzuki, Takehiro; Niizuma, Kuniyasu; Ito, Sadayoshi; Tomioka, Yoshihisa; Abe, Takaaki. Immuno-Northern Blotting: Detection of RNA Modifications by Using Antibodies against Modified Nucleosides. Plos One. 10(11):e0143756. PubMed |
| Mishima, Eikan; Abe, Takaaki. Immuno-Northern Blotting: Detection of Modified RNA Using Gel Separation and Antibodies to Modified Nucleosides. Methods In Molecular Biology (Clifton, N.j.). 1870:179-187. PubMed |
| Stockert, Jennifer A; Gupta, Akriti; Herzog, Bryan; Yadav, Shalini S; Tewari, Ashutosh K; Yadav, Kamlesh K. Predictive value of pseudouridine in prostate cancer. American Journal Of Clinical And Experimental Urology. 7(4):262-272. PubMed |